Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Gran Recovery and Health A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.0% 1.3% 0.9% 1.6% 1.5% 1.1% 7.6% 7.6%   Credit score (0-100)   88 79 89 74 75 84 32 32   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   11,025.9 2,144.1 15,991.4 515.5 861.9 4,636.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -31.3 -36.2 -401 -133 -141 -122 0.0 0.0   EBITDA   -31.3 -36.2 -401 -133 -141 -122 0.0 0.0   EBIT   -31.3 -36.2 -401 -133 -141 -122 0.0 0.0   Pre-tax profit (PTP)   7,314.1 14,784.3 8,179.1 -3,223.8 -6,341.0 17,119.5 0.0 0.0   Net earnings   7,314.1 13,700.3 5,367.7 -1,126.2 -7,844.2 15,995.4 0.0 0.0   Pre-tax profit without non-rec. items   7,314 14,784 8,179 -3,224 -6,341 17,119 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   187,866 202,614 205,231 215,260 197,526 130,119 113,462 113,462   Interest-bearing liabilities   1,900 76,670 37,376 32,844 36,079 44,312 0.0 0.0   Balance sheet total (assets)   189,797 280,403 245,465 248,118 234,947 175,826 113,462 113,462   Net Debt   1,900 2,686 -56,590 -48,268 -40,638 42,682 -113,462 -113,462     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -31.3 -36.2 -401 -133 -141 -122 0.0 0.0   Gross profit growth   0.0% -15.9% -1,006.8% 66.7% -6.0% 13.5% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   189,797 280,403 245,465 248,118 234,947 175,826 113,462 113,462   Balance sheet change%   0.0% 47.7% -12.5% 1.1% -5.3% -25.2% -35.5% 0.0%   Added value   -31.3 -36.2 -400.7 -133.4 -141.4 -122.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.9% 6.4% 3.1% 4.2% -2.1% 9.0% 0.0% 0.0%   ROI %   3.9% 6.4% 3.2% 4.2% -2.1% 9.1% 0.0% 0.0%   ROE %   3.9% 7.0% 2.6% -0.5% -3.8% 9.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   99.0% 72.3% 83.6% 86.8% 84.1% 74.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -6,080.0% -7,418.0% 14,122.3% 36,195.8% 28,739.2% -34,886.5% 0.0% 0.0%   Gearing %   1.0% 37.8% 18.2% 15.3% 18.3% 34.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.6% 0.1% 38.8% 4.0% 3.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.0 1.0 2.5 2.7 2.6 0.6 0.0 0.0   Current Ratio   1.0 1.0 2.5 2.7 2.6 0.6 0.0 0.0   Cash and cash equivalent   0.0 73,984.7 93,965.4 81,112.5 76,716.8 1,630.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -31.3 -75,681.9 -30,107.3 -24,085.8 -15,184.8 -17,144.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0